Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis

Abroad (travel likely)RecruitingPHASE2

Conditions

Systemic Sclerosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Hospital for Special Surgery, New York, New York, United States
Contact: Study coordinator (Liza Morales) · moralesli@hss.edu · 212-774-2048

Study leads

Robert Spiera, MD
Principal Investigator
Hospital for Special Surgery, New York

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)

Diffuse Cutaneous Systemic Sclerosis

Abroad (travel likely)RecruitingPHASE2

Newport Beach, United States · Clearwater, United States

Subcutaneous Injection of Sodium Thiosulfate for Ectopic Calcifications or Ossifications. A Pilot Study

Systemic Sclerosis · Dermatomyositis · iPPSD2

Abroad (travel likely)RecruitingPHASE2

Bordeaux, France · Bron, France

Controlling Hyperactive Immunity With Long-lived Lymphocytes

Diffuse Cutaneous Systemic Sclerosis · Rheumatoid Arthritis (RA) · Systemic Sclerosis (SSc)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Birmingham, United Kingdom · Leeds, United Kingdom

A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis

Systemic Sclerosis (SSc)

Abroad (travel likely)RecruitingPHASE2

Phoenix, United States · Los Angeles, United States